GRANT WEBB: Open Payments
NPI 1144645177 · GAINESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 23 payments from 9 companies in 2025. Trend: 2023 $227 · 2024 $330 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Lilly USA, LLC | 2 | $33 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, VOQUEZNA, MOUNJARO, VYNDAQEL, BREZTRI, DAYBUE, OTEZLA.
Industry payments across TX — which companies pay providers there.
